1
|
Merlo CA, Clark SC, Arnaoutakis GJ, Yonan N, Thomas D, Simon A, Thompson R, Thomas H, Orens J, Shah AS. National Healthcare Delivery Systems Influence Lung Transplant Outcomes for Cystic Fibrosis. Am J Transplant 2015; 15:1948-57. [PMID: 25809545 DOI: 10.1111/ajt.13226] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2014] [Revised: 01/11/2015] [Accepted: 01/15/2015] [Indexed: 01/25/2023]
Abstract
Successful lung transplantation (LTx) depends on multiple components of healthcare delivery and performance. Therefore, we conducted an international registry analysis to compare post-LTx outcomes for cystic fibrosis (CF) patients using the UNOS registry in the United States and the National Health Service (NHS) Transplant Registry in the United Kingdom. Patients with CF who underwent lung or heart-lung transplantation in the United States or United Kingdom between January 1, 2000 and December 31, 2011 were included. The primary outcome was all-cause mortality. Kaplan-Meier analysis and Cox proportional hazards regression evaluated the effect of healthcare system and insurance on mortality after LTx. 2,307 US LTx recipients and 451 individuals in the United Kingdom were included. 894 (38.8%) US LTx recipients had publically funded Medicare/Medicaid insurance. US private insurance and UK patients had improved median predicted survival compared with US Medicare/Medicaid recipients (p < 0.001). In multivariable Cox regression, US Medicare/Medicaid insurance was associated with worse survival after LTx (US private: HR0.78,0.68-0.90,p = 0.001 and UK: HR0.63,0.41-0.97, p = 0.03). This study in CF patients is the largest comparison of LTx in two unique health systems. Both the United States and United Kingdom have similar early survival outcomes, suggesting important dissemination of best practices internationally. However, the performance of US public insurance is significantly worse and may put patients at risk.
Collapse
Affiliation(s)
- C A Merlo
- Divisions of Pulmonary and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, MD.,The Bloomberg School of Public Health, The Johns Hopkins Medical Institutions, Baltimore, MD
| | - S C Clark
- Department of Cardiothoracic Transplantation and Surgery, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
| | - G J Arnaoutakis
- Division of Cardiac Surgery, The Johns Hopkins Medical Institutions, Baltimore, MD
| | - N Yonan
- North West Heart Centre and The Transplant Centre, University Hospital of South Manchester, Manchester, United Kingdom
| | - D Thomas
- Papworth Hospitals, NHS Trust Cambridge, Cambridge, United Kingdom
| | - A Simon
- Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, Middlesex, United Kingdom
| | - R Thompson
- Department of Heart and Lung Transplantation, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom
| | - H Thomas
- Department of Heart and Lung Transplantation, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom
| | - J Orens
- Divisions of Pulmonary and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, MD
| | - A S Shah
- Division of Cardiac Surgery, The Johns Hopkins Medical Institutions, Baltimore, MD
| |
Collapse
|